ILSI-Biomed Israel

May 5th: Healthcare Reform Webinar

U.S. Health Care Reform Webinar - A Special Presentation for Israeli Pharma, Biotech and Medical Device Companies and Their Investors     Please register for this live webinar.   Meeting Description:    Drug and Biologics Manufacturers: Medicare and Medicaid drug coverage changes Annual fee for branded prescription drug manufacturers Biosimilars   Medical Device Manufacturers: Excise tax Essential Health Benefits Package   Heal...

May 11th: Seminar on Advantages of Manufacturing in Israel

SAVE THE DATE May 11th, 16:00-19:00 Beit Chel Ha’avir, 15  Jabotinski Street, Herzelia Advantages of Manufacturing in Israel The seminar will focus on issues related to options, advantages and Governmental policies associated with manufacturing of Medical Devices and Biopharma products in Israel.  The event will be moderated by Moshe Mizrahy, founder of Nitzanim Medical Fund  Agenda 16:00-16:20           Moshe Mizrahy - Introduction 16:20-16:40           Dr. Ora Dar, ...

The Power Solution: Thermoelectric Generators to Sustain Implanted Medical Devices

Efficient thermoelectric generators were recently published as a possibly efficient way to sustain implanted medical devices Let's face it: we're dealing with an aging population. There's no way around this fact, and the obvious implication is that in the future we're going to need better heart pacemakers and better systems for insulin injection. The future seems to be heading towards more sophisticated implantable machinery, be it pacemakers or sustainable drug-release devices inside the bod...

June 15th, 2010: A Meeting with the Sheba & Rambam Campus Scientists

June 15th, 2010: A Meeting with the Sheba & Rambam Campus Scientists

Plastics that Distort DNA Readings

A new research reveals that polypropylene tubes can contaminate solutions in the PCR and distort the DNA spectrometer readings. One year ago, a group of researchers at Hadassah-Hebrew University Medical Center in Jerusalem reported a sharp rise in the diagnoses of a certain metabolic disorder. To those of us who live in Jerusalem, fear not. Other than the Holyland story, nothing really happened in the Israeli capital in the last year. The only change is that the lab at Hadassah changed th...

3-6 May: Bio International Convention in Chicago

On May 3rd to 6th, the global event for biotechnology will go open in Chicago, with more than 1,700 exhibitions, and a strong Israeli presence. To the Conference Site Schedule of Events Bio- International Convention 2010 May 3rd – 6th Companies exhibiting and holding meetings at the Israel national pavilion. Booth #2548 Monday, May 3rd AICC LSPG Mission Breakfast Event, Brinks Hofer Gilson & Lione, NBC Tower, Suite 3600 455 North Cityfront Plaza Drive, 7:00 – 10:30 AM Tuesday, M...

First worldwide patients treated with anti-adhesion SpineShield

Magen Medical Solutions Ltd., a medical device company developing unique anti-adhesion devices for orthopedic applications, is pleased to announce that it has successfully implanted its first product, the SpineShield, in three patients at a clinical site in Europe. Post-operative adhesion is considered a major cause of failed back surgery. In up to 15% of cases, patients suffer from pain due to spinal adhesion, or scar tissue formation around the spinal cord, which may require a second su...

The Potential of Smart-phones in Biomedicine

Medical apps for iPhone can be found aplenty, and soon to come are biomedical apps that interact with implants and monitor vital signs. A few weeks ago I received my first iPhone, and ever since I’ve had a blast of a time. This single, tiny device, can take the place of so many other utilities: books, movie and music players and yes – even portable game systems. It all depends on the apps you choose to download to your iPhone, of which there is a wide variety. Of all the applications I ve...

Avraham Pharmaceuticals: $9 M Funding for a Multy-functional Alzheimer drug

Avraham Pharmaceuticals Ltd. has raised $9 million from Yissum Research Development Company (the technology transfer arm of the Hebrew University of Jerusalem), Pontifax, Clal Biotechnology Industries (CBI), Professor Marta Weinstock-Rosin and others.   Yissum has announced that, together with the Technion Research and Development Foundation (TRDF), the technology transfer arm of the Technion Israel Institute of Technology, it will exclusively license to Avraham the commercial rights of La...